These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 24747343)

  • 21. Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.
    Hayes FJ; Taylor AE; Martin KA; Hall JE
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2343-9. PubMed ID: 9661606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired steroid hormone feedback in polycystic ovary syndrome: Evidence from preclinical models for abnormalities within central circuits controlling fertility.
    Moore AM
    Clin Endocrinol (Oxf); 2022 Aug; 97(2):199-207. PubMed ID: 35349177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide galanin and its effects on metabolic and reproductive disturbances in female rats with estradiol valerate (EV) - Induced polycystic ovary syndrome (PCOS).
    Azin F; Khazali H
    Neuropeptides; 2020 Apr; 80():102026. PubMed ID: 32063381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome.
    Moore AM; Prescott M; Marshall CJ; Yip SH; Campbell RE
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):596-601. PubMed ID: 25550522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated Episodic Luteinizing Hormone Release Accompanies Blunted Progesterone Regulation in PCOS-like Female Rhesus Monkeys (Macaca Mulatta) Exposed to Testosterone during Early-to-Mid Gestation.
    Abbott DH; Vepraskas SH; Horton TH; Terasawa E; Levine JE
    Neuroendocrinology; 2018; 107(2):133-146. PubMed ID: 29949806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of a Classic Hunger Circuit Slows Luteinizing Hormone Pulsatility.
    Coutinho EA; Prescott M; Hessler S; Marshall CJ; Herbison AE; Campbell RE
    Neuroendocrinology; 2020; 110(7-8):671-687. PubMed ID: 31630145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen Inhibition of Reproductive Neuroendocrine Function in Females and Transgender Males.
    Kauffman AS
    Endocrinology; 2024 Aug; 165(10):. PubMed ID: 39207217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overactivation of GnRH neurons is sufficient to trigger polycystic ovary syndrome-like traits in female mice.
    Silva MSB; Decoster L; Delpouve G; Lhomme T; Ternier G; Prevot V; Giacobini P
    EBioMedicine; 2023 Nov; 97():104850. PubMed ID: 37898094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycystic Ovary Syndrome and the Neuroendocrine Consequences of Androgen Excess.
    Silva MSB; Campbell RE
    Compr Physiol; 2022 Mar; 12(2):3347-3369. PubMed ID: 35578968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.
    Cheung AP; Lu JK; Chang RJ
    Hum Reprod; 1997 Jun; 12(6):1156-64. PubMed ID: 9221993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A; Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic Dysfunctions.
    Cardoso RC; Puttabyatappa M; Padmanabhan V
    Neuroendocrinology; 2015; 102(3):226-37. PubMed ID: 25832114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadotrophin-releasing hormone receptor autoantibodies induce polycystic ovary syndrome-like features in a rat model.
    Li H; Guo Y; Zhang G; Deng J; Fischer H; Craig LB; Yu X; Kem DC
    Exp Physiol; 2021 Apr; 106(4):902-912. PubMed ID: 33576068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia?
    Levin JH; Carmina E; Lobo RA
    Fertil Steril; 1991 Oct; 56(4):635-40. PubMed ID: 1915936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
    Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
    Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.
    Patel K; Coffler MS; Dahan MH; Malcom PJ; Deutsch R; Chang RJ
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):67-74. PubMed ID: 14678290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal androgen excess enhances stimulation of the GNRH pulse in pubertal female rats.
    Yan X; Yuan C; Zhao N; Cui Y; Liu J
    J Endocrinol; 2014 Jul; 222(1):73-85. PubMed ID: 24829217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.
    Pagán YL; Srouji SS; Jimenez Y; Emerson A; Gill S; Hall JE
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1309-16. PubMed ID: 16434454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
    Berga SL; Yen SS
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
    Ruchhoft EA; Elkind-Hirsch KE; Malinak R
    Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.